Manifest Disease, Risk Factors for Sudden Cardiac Death, and Cardiac Events in a Large Nationwide Cohort of Predictively Tested Hypertrophic Cardiomyopathy Mutation Carriers: Determining the Best Cardiological Screening Strategy

Study Questions:

What is the best way to screen relatives of patients with hypertrophic cardiomyopathy (HCM) who carry the putative mutation?